| Year |
Citation |
Score |
| 2023 |
Homaira N, Strachan R, Quinn H, Beggs S, Bhuiyan M, Bowen A, Fawcett LK, Gilbert GL, Lambert SB, Macartney K, Marshall HS, Martin AC, McCallum G, McCullagh A, McDonald T, ... ... McIntyre P, et al. Erratum to "Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study" [Vaccine 41(1) (2023) 85-91]. Vaccine. PMID 37625991 DOI: 10.1016/j.vaccine.2023.07.039 |
0.313 |
|
| 2023 |
Kabir A, Randall D, Newall AT, Moore HC, Jayasinghe S, Fathima P, Liu B, McIntyre P, Gidding HF. Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage study. Vaccine. PMID 37507273 DOI: 10.1016/j.vaccine.2023.07.042 |
0.331 |
|
| 2023 |
Thindwa D, Clifford S, Kleynhans J, von Gottberg A, Walaza S, Meiring S, Swarthout TD, Miller E, McIntyre P, Andrews N, Amin-Chowdhury Z, Fry N, Jambo KC, French N, Almeida SCG, et al. Optimal age targeting for pneumococcal vaccination in older adults; a modelling study. Nature Communications. 14: 888. PMID 36797259 DOI: 10.1038/s41467-023-36624-8 |
0.348 |
|
| 2022 |
Jayasundara D, Randall D, Sheridan S, Sheppeard V, Liu B, Richmond PC, Blyth CC, Wood JG, Moore HC, McIntyre PB, Gidding HF. Estimating the excess burden of pertussis disease in Australia within the first year of life, that might have been prevented through timely vaccination. International Journal of Epidemiology. PMID 36099159 DOI: 10.1093/ije/dyac175 |
0.303 |
|
| 2022 |
Patel C, Dey A, Wang H, McIntyre P, Macartney K, Beard F. Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018 Final Report. Communicable Diseases Intelligence (2018). 46. PMID 35739072 DOI: 10.33321/cdi.2022.46.28 |
0.319 |
|
| 2022 |
Gianacas C, Muscatello D, Blogg S, Kirk M, McIntyre P, Cheng A, Liu B. Effectiveness of Influenza Vaccination in Reducing Subsequent Antibiotic Prescribing in Young Children Attending Australian General Practices-A Case-Control Study. Journal of the Pediatric Infectious Diseases Society. PMID 35395082 DOI: 10.1093/jpids/piac021 |
0.312 |
|
| 2022 |
Sheel M, Wood N, Macartney K, Buttery J, Dinsmore N, Marshall H, Elliott E, Kynaston A, Richmond P, Chateau D, McIntyre P. Severity of Rotavirus-Vaccine-Associated Intussusception: Prospective Hospital-Based Surveillance, Australia, 2007-2018. The Pediatric Infectious Disease Journal. PMID 35363642 DOI: 10.1097/INF.0000000000003521 |
0.317 |
|
| 2022 |
Sheridan S, McIntyre P, Liu B, Fathima P, Snelling T, Blyth C, Klerk N, Moore H, Gidding H. Pertussis burden and acellular pertussis vaccine effectiveness in high risk children. Vaccine. PMID 35101268 DOI: 10.1016/j.vaccine.2021.10.013 |
0.302 |
|
| 2021 |
McIntyre PB, Aggarwal R, Jani I, Jawad J, Kochhar S, MacDonald N, Madhi SA, Mohsni E, Mulholland K, Neuzil KM, Nohynek H, Olayinka F, Pitisuttithum P, Pollard AJ, Cravioto A. COVID-19 vaccine strategies must focus on severe disease and global equity. Lancet (London, England). PMID 34922639 DOI: 10.1016/S0140-6736(21)02835-X |
0.305 |
|
| 2021 |
Quinn HE, Comeau JL, Marshall HS, Elliott EJ, Crawford NW, Blyth CC, Kynaston JA, Snelling TL, Richmond PC, Francis JR, Macartney KK, McIntyre PB, Wood NJ. Pertussis Disease and Antenatal Vaccine Effectiveness in Australian Children. The Pediatric Infectious Disease Journal. PMID 34711785 DOI: 10.1097/INF.0000000000003367 |
0.337 |
|
| 2021 |
Flanagan KL, MacIntyre CR, McIntyre PB, Nelson MR. SARS-CoV-2 Vaccines: Where Are We Now? The Journal of Allergy and Clinical Immunology. in Practice. PMID 34400116 DOI: 10.1016/j.jaip.2021.07.016 |
0.345 |
|
| 2021 |
Chan J, Gidding HF, Blyth CC, Fathima P, Jayasinghe S, McIntyre PB, Moore HC, Mulholland K, Nguyen CD, Andrews R, Russell FM. Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study. Plos Medicine. 18: e1003733. PMID 34343186 DOI: 10.1371/journal.pmed.1003733 |
0.333 |
|
| 2021 |
Hull B, Hendry A, Dey A, McIntyre P, Macartney K, Beard F. Immunisation Coverage Annual Report 2018. Communicable Diseases Intelligence (2018). 45. PMID 33823757 DOI: 10.33321/cdi.2020.45.17 |
0.336 |
|
| 2021 |
McIntyre P, Joo YJ, Chiu C, Flanagan K, Macartney K. COVID-19 vaccines - are we there yet? Australian Prescriber. 44: 19-25. PMID 33664546 DOI: 10.18773/austprescr.2020.084 |
0.342 |
|
| 2021 |
Kabir A, Newall AT, Randall D, Menzies R, Sheridan S, Jayasinghe S, Fathima P, Liu B, Moore H, McIntyre P, Gidding HF. Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkage. Vaccine. PMID 33622589 DOI: 10.1016/j.vaccine.2021.02.015 |
0.312 |
|
| 2021 |
Cunningham AL, McIntyre P, Subbarao K, Booy R, Levin MJ. Vaccines for older adults. Bmj (Clinical Research Ed.). 372: n188. PMID 33619170 DOI: 10.1136/bmj.n188 |
0.349 |
|
| 2021 |
Strachan R, Homaira N, Beggs S, Bhuiyan MU, Gilbert GL, Lambert SB, Macartney K, Marshall H, Martin AC, McCallum GB, McCullagh A, McDonald T, McIntyre P, Oftadeh S, Ranganathan S, et al. Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax. PMID 33504566 DOI: 10.1136/thoraxjnl-2020-216032 |
0.315 |
|
| 2020 |
Toelle BG, Garden FL, McIntyre PB, Wood N, Marks GB. Pertussis vaccination and Allergic illness in Australian children. Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology. PMID 32459867 DOI: 10.1111/pai.13300 |
0.304 |
|
| 2020 |
Maguire JE, Beard F, Méder K, Dey A, Macartney K, McIntyre P. Australian vaccine preventable disease epidemiological review series: invasive Haemophilus influenzae type b disease, 2000-2017. Communicable Diseases Intelligence (2018). 44. PMID 32114977 DOI: 10.33321/cdi.2020.44.11 |
0.325 |
|
| 2019 |
Dey A, Wang H, Beard F, Macartney K, McIntyre P. Summary of national surveillance data on vaccine preventable diseases in Australia, 2012-2015. Communicable Diseases Intelligence (2018). 43. PMID 31738873 DOI: 10.33321/cdi.2019.43.58 |
0.319 |
|
| 2019 |
Gidding HF, Flack LK, Sheridan S, Liu B, Fathima P, Sheppeard V, Richmond P, Hull B, Blyth C, Andrews RM, Snelling TL, de Klerk N, McIntyre PB, Moore HC. Infant, maternal and demographic predictors of delayed vaccination: A population-based cohort study. Vaccine. PMID 31628032 DOI: 10.1016/j.vaccine.2019.09.091 |
0.327 |
|
| 2019 |
Fathima P, Gidding HF, Snelling TL, McIntyre PB, Blyth CC, Sheridan S, Liu B, de Klerk N, Moore HC. Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study. Vaccine. PMID 31443995 DOI: 10.1016/j.vaccine.2019.08.013 |
0.303 |
|
| 2019 |
Fathima P, Gidding HF, McIntyre PB, Snelling TL, McCallum L, de Klerk N, Blyth CC, Liu B, Moore HC. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study. The Lancet. Child & Adolescent Health. PMID 31439496 DOI: 10.1016/S2352-4642(19)30249-4 |
0.334 |
|
| 2019 |
Ioannides S, Beard F, Larter N, Clark K, Wang H, Hendry A, Hull B, Dey A, Chiu C, Brotherton J, Jayasinghe S, Macartney K, McIntyre P. Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2011–2015 Communicable Diseases Intelligence (2018). 43. PMID 31412692 |
0.334 |
|
| 2019 |
Dyda A, Karki S, Kong M, Gidding HF, Kaldor JM, McIntyre P, Banks E, MacIntyre CR, Liu B. Influenza vaccination coverage in a population-based cohort of Australian-born Aboriginal and non-Indigenous older adults Communicable Diseases Intelligence (2018). 43. PMID 31315167 DOI: 10.33321/cdi.2019.43.30 |
0.317 |
|
| 2019 |
MacIntyre CR, Ridda I, Trent MJ, McIntyre P. Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up. Vaccine. PMID 31300288 DOI: 10.1016/j.vaccine.2019.07.005 |
0.309 |
|
| 2019 |
Sarna M, Andrews R, Moore H, Binks MJ, McHugh L, Pereira GF, Blyth CC, Van Buynder P, Lust K, Effler P, Lambert SB, Omer SB, Mak DB, Snelling T, D'Antoine HA, ... McIntyre P, et al. 'Links2HealthierBubs' cohort study: protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian women. Bmj Open. 9: e030277. PMID 31227542 DOI: 10.1136/Bmjopen-2019-030277 |
0.326 |
|
| 2019 |
Gidding HF, Sheridan S, Fathima P, Moore HC, Liu B, McIntyre PB, Palmu AA. Impact of Childhood Pneumococcal Conjugate Vaccine on Nonnotified Clinically Suspected Invasive Pneumococcal Disease in Australia. The Pediatric Infectious Disease Journal. PMID 30985507 DOI: 10.1097/INF.0000000000002314 |
0.329 |
|
| 2019 |
Hull B, Hendry A, Dey A, Beard F, Brotherton J, McIntyre P. Immunisation coverage annual report, 2015 Communicable Diseases Intelligence (2018). PMID 30879287 |
0.326 |
|
| 2018 |
Sheel M, Beard F, Quinn H, Dey A, Kirk M, Koehler A, Markey P, McIntyre P, Macartney K. Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998-2015. Communicable Diseases Intelligence (2018). 42. PMID 30626299 |
0.352 |
|
| 2018 |
Quinn HE, Gidding HF, Marshall HS, Booy R, Elliott EJ, Richmond P, Crawford N, McIntyre PB, Macartney KK. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program. The Journal of Infection. PMID 30528868 DOI: 10.1016/j.jinf.2018.11.009 |
0.303 |
|
| 2018 |
Chen C, Beutels P, Wood J, Menzies R, MacIntyre CR, McIntyre P, Newall AT. Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine. PMID 30213457 DOI: 10.1016/j.vaccine.2018.08.084 |
0.318 |
|
| 2018 |
Wood N, Nolan T, Marshall H, Richmond P, Gibbs E, Perrett K, McIntyre P. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial. Jama Pediatrics. PMID 30208475 DOI: 10.1001/jamapediatrics.2018.2349 |
0.312 |
|
| 2018 |
Jayasinghe S, Chiu C, Quinn H, Menzies R, Gilmour R, McIntyre P. Effectiveness of Seven and Thirteen Valent Pneumococcal Conjugate Vaccines in a Schedule without a Booster dose: a Ten Year Observational Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29471432 DOI: 10.1093/cid/ciy129 |
0.331 |
|
| 2018 |
Chen C, Wood JG, Beutels P, Menzies R, MacIntyre CR, Dirmesropian S, Reyes JF, McIntyre P, Newall AT. The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia. Vaccine. PMID 29395534 DOI: 10.1016/j.vaccine.2018.01.052 |
0.342 |
|
| 2017 |
Beard FH, Leask J, McIntyre PB. No Jab, No Pay and vaccine refusal in Australia: the jury is out. The Medical Journal of Australia. 207: 407. PMID 29297649 DOI: 10.5694/mja17.00566 |
0.329 |
|
| 2017 |
Sheel M, Beard FH, Dey A, Macartney K, McIntyre PB. Rates of hospitalisation for herpes zoster may warrant vaccinating Indigenous Australians under 70. The Medical Journal of Australia. 207: 395-396. PMID 29092706 DOI: 10.5694/mja16.01468 |
0.311 |
|
| 2017 |
Macartney K, Gidding HF, Trinh L, Wang H, Dey A, Hull B, Orr K, McRae J, Richmond P, Gold M, Crawford N, Kynaston JA, McIntyre P, Wood N. Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia. Jama Pediatrics. PMID 28806450 DOI: 10.1001/jamapediatrics.2017.1965 |
0.327 |
|
| 2017 |
Beard FH, Leask J, McIntyre PB. No Jab, No Pay and vaccine refusal in Australia: the jury is out. The Medical Journal of Australia. 206: 381-383. PMID 28490296 DOI: 10.5694/mja16.00944 |
0.329 |
|
| 2017 |
Hull BP, Hendry AJ, Dey A, Beard FH, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2014. Communicable Diseases Intelligence Quarterly Report. 41: E68-E90. PMID 28385140 |
0.313 |
|
| 2016 |
Jayasinghe S, Menzies R, Chiu C, Toms C, Blyth CC, Krause V, McIntyre P. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27986682 DOI: 10.1093/cid/ciw720 |
0.31 |
|
| 2016 |
Saadatian-Elahi M, Plotkin S, Mills KH, Halperin SA, McIntyre PB, Picot V, Louis J, Johnson DR. Pertussis: Biology, epidemiology and prevention. Vaccine. PMID 27780629 DOI: 10.1016/j.vaccine.2016.10.029 |
0.339 |
|
| 2016 |
Karki S, Dyda A, Newall A, Heywood A, MacIntyre CR, McIntyre P, Banks E, Liu B. Comparison of influenza vaccination coverage between immigrant and Australian-born adults. Vaccine. PMID 27742215 DOI: 10.1016/j.vaccine.2016.10.012 |
0.335 |
|
| 2016 |
Holt PG, Snelling T, White OJ, Sly PD, DeKlerk N, Carapetis J, Biggelaar AV, Wood N, McIntyre P, Gold M. Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine? Vaccine. PMID 27265452 DOI: 10.1016/j.vaccine.2016.05.048 |
0.337 |
|
| 2016 |
Lawrence GL, Wang H, Lahra M, Booy R, McINTYRE PB. Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme. Epidemiology and Infection. 1-10. PMID 27094814 DOI: 10.1017/S0950268816000704 |
0.319 |
|
| 2015 |
Jayasinghe S, Chiu C, Menzies R, Lehmann D, Cook H, Giele C, Krause V, McIntyre P. Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children. Vaccine. PMID 26519550 DOI: 10.1016/j.vaccine.2015.10.089 |
0.341 |
|
| 2015 |
Campbell PT, McCaw JM, McIntyre P, McVernon J. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies. Vaccine. 33: 5794-800. PMID 26392008 DOI: 10.1016/j.vaccine.2015.09.025 |
0.307 |
|
| 2015 |
Chiew M, Dey A, Martin N, Wang H, Davis S, McIntyre PB. Australian vaccine preventable disease epidemiological review series: measles 2000-2011. Communicable Diseases Intelligence Quarterly Report. 39: E1-9. PMID 26063085 |
0.344 |
|
| 2015 |
Dyda A, MacIntyre CR, McIntyre P, Newall AT, Banks E, Kaldor J, Liu B. Factors associated with influenza vaccination in middle and older aged Australian adults according to eligibility for the national vaccination program. Vaccine. 33: 3299-305. PMID 26036944 DOI: 10.1016/j.vaccine.2015.05.046 |
0.307 |
|
| 2015 |
Menzies RI, Bremner KM, Wang H, Beard FH, McIntyre PB. Long-term trends in invasive Haemophilus influenzae type B disease among indigenous Australian children following use of PRP-OMP and PRP-T vaccines. The Pediatric Infectious Disease Journal. 34: 621-6. PMID 25973940 DOI: 10.1097/INF.0000000000000681 |
0.308 |
|
| 2015 |
Wood JG, Goeyvaerts N, MacIntyre CR, Menzies RI, McIntyre PB, Hens N. Estimating vaccine coverage from serial trivariate serologic data in the presence of waning immunity. Epidemiology (Cambridge, Mass.). 26: 381-9. PMID 25764249 DOI: 10.1097/Ede.0000000000000278 |
0.325 |
|
| 2015 |
Gao Z, Wood JG, Gidding HF, Newall AT, Menzies RI, Wang H, McINTYRE PB, Macintyre CR. Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future - CORRIGENDUM. Epidemiology and Infection. 143: 1651. PMID 25732772 DOI: 10.1017/S0950268815000308 |
0.313 |
|
| 2015 |
Gao Z, Wood JG, Gidding HF, Newall AT, Menzies RI, Wang H, McIntyre PB, MacIntyre CR. Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future. Epidemiology and Infection. 143: 1467-76. PMID 25222565 DOI: 10.1017/S0950268814002222 |
0.333 |
|
| 2014 |
Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage, 2012. Communicable Diseases Intelligence Quarterly Report. 38: E208-31. PMID 25391407 |
0.339 |
|
| 2014 |
Pillsbury A, Quinn HE, McIntyre PB. Australian vaccine preventable disease epidemiological review series: pertussis, 2006-2012. Communicable Diseases Intelligence Quarterly Report. 38: E179-94. PMID 25391404 |
0.356 |
|
| 2014 |
Sheridan SL, Frith K, Snelling TL, Grimwood K, McIntyre PB, Lambert SB. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Review of Vaccines. 13: 1081-106. PMID 25093268 DOI: 10.1586/14760584.2014.944167 |
0.344 |
|
| 2014 |
Macartney K, Heywood A, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. The Cochrane Database of Systematic Reviews. 6: CD001833. PMID 24954057 DOI: 10.1002/14651858.CD001833.pub3 |
0.307 |
|
| 2014 |
Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, McIntyre P, Marshall H, Guiso N, Keil AD, Lawrence A, Robson J, Hogg G, Lan R. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerging Infectious Diseases. 20: 626-33. PMID 24655754 DOI: 10.3201/eid2004.131478 |
0.305 |
|
| 2014 |
Dey A, Gidding HF, Menzies R, McIntyre P. General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events. Vaccine. 32: 2204-8. PMID 24613527 DOI: 10.1016/j.vaccine.2014.02.044 |
0.323 |
|
| 2014 |
Menzies RI, Jayasinghe SH, Krause VL, Chiu CK, McIntyre PB. Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older. The Medical Journal of Australia. 200: 112-5. PMID 24484116 DOI: 10.5694/mja12.11759 |
0.332 |
|
| 2014 |
Newall AT, Reyes JF, Wood JG, McIntyre P, Menzies R, Beutels P. Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses. Vaccine. 32: 759-65. PMID 24295806 DOI: 10.1016/j.vaccine.2013.11.067 |
0.307 |
|
| 2013 |
Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2011. Communicable Diseases Intelligence Quarterly Report. 37: E291-312. PMID 24882234 |
0.325 |
|
| 2013 |
Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H, McIntyre P, Menzies R. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010. Communicable Diseases Intelligence Quarterly Report. 37: S1-95. PMID 24410428 |
0.371 |
|
| 2013 |
Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre PB. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1427-34. PMID 23964090 DOI: 10.1093/cid/cit520 |
0.303 |
|
| 2013 |
Hull B, Dey A, Menzies R, McIntyre P. Annual immunisation coverage report, 2010. Communicable Diseases Intelligence Quarterly Report. 37: E21-39. PMID 23692156 |
0.341 |
|
| 2013 |
Hull BP, Menzies R, Macartney K, McIntyre PB. Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience. Vaccine. 31: 1964-9. PMID 23422140 DOI: 10.1016/j.vaccine.2013.02.007 |
0.347 |
|
| 2013 |
Guo B, Page A, Wang H, Taylor R, McIntyre P. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China. Vaccine. 31: 603-17. PMID 23200940 DOI: 10.1016/J.Vaccine.2012.11.051 |
0.305 |
|
| 2013 |
Gao Z, Wood JG, Burgess MA, Menzies RI, McIntyre PB, MacIntyre CR. Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia. Vaccine. 31: 691-7. PMID 23196206 DOI: 10.1016/j.vaccine.2012.11.043 |
0.322 |
|
| 2013 |
Chiu C, McIntyre P. Pneumococcal vaccines – past, present and future Australian Prescriber. 36: 88-93. DOI: 10.18773/AUSTPRESCR.2013.035 |
0.324 |
|
| 2012 |
McIntyre PB, O'Brien KL, Greenwood B, van de Beek D. Effect of vaccines on bacterial meningitis worldwide. Lancet. 380: 1703-11. PMID 23141619 DOI: 10.1016/S0140-6736(12)61187-8 |
0.334 |
|
| 2012 |
Song N, Gao Z, Wood JG, Hueston L, Gilbert GL, MacIntyre CR, Quinn HE, Menzies R, McIntyre P. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination. Vaccine. 30: 4073-8. PMID 22554644 DOI: 10.1016/j.vaccine.2012.04.025 |
0.319 |
|
| 2012 |
Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, Sáfadi MA. The changing and dynamic epidemiology of meningococcal disease. Vaccine. 30: B26-36. PMID 22178525 DOI: 10.1016/J.Vaccine.2011.12.032 |
0.308 |
|
| 2012 |
Wood N, Sheppeard V, Cashman P, Palasanthiran P, Casacelli M, Cannings K, McIntyre P. Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in Australia. The Pediatric Infectious Disease Journal. 31: 199-202. PMID 22094632 DOI: 10.1097/INF.0b013e31823d5303 |
0.324 |
|
| 2012 |
Ridda I, McIntyre PB. Tdap: a new option for pertussis booster vaccination of seniors Aging Health. 8: 449-455. DOI: 10.2217/AHE.12.54 |
0.333 |
|
| 2011 |
Mahajan D, Cook J, McIntyre PB, Macartney K, Menzies RI. Annual report: surveillance of adverse events following immunisation in Australia, 2010. Communicable Diseases Intelligence Quarterly Report. 35: 263-80. PMID 22624487 |
0.328 |
|
| 2011 |
Hull B, Dey A, Mahajan D, Menzies R, McIntyre PB. Immunisation coverage annual report, 2009. Communicable Diseases Intelligence Quarterly Report. 35: 132-48. PMID 22010506 |
0.342 |
|
| 2011 |
Van Damme P, McIntyre P, Grimprel E, Kuriyakose S, Jacquet JM, Hardt K, Messier M, Van Der Meeren O. Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials. Vaccine. 29: 5932-9. PMID 21718738 DOI: 10.1016/j.vaccine.2011.06.049 |
0.318 |
|
| 2011 |
Quinn P, Gold M, Royle J, Buttery J, Richmond P, McIntyre P, Wood N, Lee SS, Marshall H. Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine. 29: 4230-7. PMID 21497629 DOI: 10.1016/j.vaccine.2011.03.088 |
0.302 |
|
| 2010 |
Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D, Macartney K, Brotherton J, Jardine A, Quinn H, Jelfs J, Booy R, Lawrence G, Jayasinghe S, Roberts-Witteveen A, ... ... McIntyre P, et al. Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence Quarterly Report. 34: S1-167. PMID 21416762 |
0.321 |
|
| 2010 |
Hull BP, Mahajan D, Dey A, Menzies RI, McIntyre PB. Immunisation coverage annual report, 2008. Communicable Diseases Intelligence Quarterly Report. 34: 241-58. PMID 21090180 |
0.343 |
|
| 2010 |
McIntyre P. Commentary on opinion pieces re Australian human papillomavirus vaccine policy Sexual Health. 7: 242-243. PMID 21058498 DOI: 10.1071/SH10026 |
0.303 |
|
| 2010 |
Gold MS, McIntyre P. Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance. Sexual Health. 7: 320-4. PMID 20719221 DOI: 10.1071/SH09153 |
0.309 |
|
| 2009 |
Menzies R, Mahajan D, Gold MS, Roomiani I, McIntyre P, Lawrence G. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Communicable Diseases Intelligence Quarterly Report. 33: 365-81. PMID 20301966 |
0.325 |
|
| 2009 |
Ladhani S, Heath PT, Slack MP, McIntyre PB, Diez-Domingo J, Campos J, Dagan R, Ramsay ME. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 16: 948-54. PMID 19889054 DOI: 10.1111/j.1469-0691.2009.02945.x |
0.308 |
|
| 2009 |
Leask J, McIntyre PB. Vaccine refusal and the risks of vaccine-preventable diseases. The New England Journal of Medicine. 361: 723; author reply 72. PMID 19681177 |
0.322 |
|
| 2009 |
Rank C, Quinn HE, McIntyre PB. Pertussis vaccine effectiveness after mass immunization of high school students in Australia. The Pediatric Infectious Disease Journal. 28: 152-3. PMID 19106780 DOI: 10.1097/INF.0b013e318185608e |
0.3 |
|
| 2009 |
McIntyre PB, Burgess MA, Egan A, Schuerman L, Hoet B. Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination. Vaccine. 27: 1062-6. PMID 19095033 DOI: 10.1016/j.vaccine.2008.11.102 |
0.304 |
|
| 2009 |
Wang H, Deeks S, Glasswell A, McIntyre P. Trends in invasive Haemophilus influenzae type B disease in Australia, 1995-2005. Communicable Diseases Intelligence Quarterly Report. 32: 316-25. PMID 19062767 |
0.346 |
|
| 2009 |
Wood JG, Gidding HF, Heywood A, Macartney K, McIntyre PB, Macintyre CR. Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia. Vaccine. 27: 313-8. PMID 18977272 DOI: 10.1016/j.vaccine.2008.09.095 |
0.317 |
|
| 2009 |
Ridda I, MacIntyre C, Lindley R, Gao Z, Sullivan J, Yuan F, McIntyre P. Corrigendum to “Immunological responses to pneumococcal vaccine in frail older people” [Vaccine 27 (2009) 1628–1636] Vaccine. 27: 6649. DOI: 10.1016/J.VACCINE.2009.06.001 |
0.324 |
|
| 2008 |
Lawrence G, Gold MS, Hill R, Deeks S, Glasswell A, McIntyre PB. Annual report: surveillance of adverse events following immunisation in Australia, 2007. Communicable Diseases Intelligence Quarterly Report. 32: 371-87. PMID 19374268 |
0.31 |
|
| 2008 |
Ridda I, Macintyre CR, Lindley R, Gao Z, Sullivan JS, Yuan FF, McIntyre PB. Immunological responses to pneumococcal vaccine in frail older people. Vaccine. 27: 1628-36. PMID 19100304 DOI: 10.1016/j.vaccine.2008.11.098 |
0.301 |
|
| 2008 |
Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Communicable Diseases Intelligence Quarterly Report. S2-67. PMID 18711998 |
0.367 |
|
| 2008 |
Ridda I, Lindley IR, Gao Z, McIntyre P, Macintyre CR. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine. 26: 5633-40. PMID 18706955 DOI: 10.1016/j.vaccine.2008.07.070 |
0.305 |
|
| 2008 |
Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention Paediatric Respiratory Reviews. 9: 201-212. PMID 18694712 DOI: 10.1016/j.prrv.2008.05.010 |
0.316 |
|
| 2008 |
Macartney K, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. The Cochrane Database of Systematic Reviews. CD001833. PMID 18646079 DOI: 10.1002/14651858.CD001833.pub2 |
0.306 |
|
| 2008 |
McIntyre P, Leask J. Improving uptake of MMR vaccine Bmj. 336: 729-730. PMID 18309963 DOI: 10.1136/bmj.39503.508484.80 |
0.311 |
|
| 2008 |
Chiu C, Ridley G, Menzies R, McIntyre P. Update on childhood pneumococcal vaccination Pediatric Health. 2: 351-365. DOI: 10.2217/17455111.2.3.351 |
0.352 |
|
| 2007 |
Lawrence GL, Aratchige PE, Boyd I, McIntyre PB, Gold MS. Annual report on surveillance of adverse events following immunisation in Australia, 2006. Communicable Diseases Intelligence Quarterly Report. 31: 269-82. PMID 17974219 |
0.323 |
|
| 2007 |
Brotherton J, Wang H, Schaffer A, Quinn H, Menzies R, Hull B, Lawrence G, Wood J, Wood N, Rosewell A, Newall A, MacIntyre R, Macartney K, Gidding H, McIntyre P, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence Quarterly Report. 31: S1-152. PMID 17844780 |
0.334 |
|
| 2007 |
Hull BP, McIntyre PB. Compliance with three simultaneous vaccinations due at the one visit at 12 months of age in Australia Communicable Diseases Intelligence. 31: 198-202. PMID 17724995 |
0.335 |
|
| 2007 |
Ridda I, MacIntyre RC, Lindley RI, McIntyre PB, Sullivan J, Gilbert G, Kovoor P, Manolios N, Fox J. Predictors of pneumococcal vaccination uptake in hospitalized patients aged 65 years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia. Human Vaccines. 3: 83-6. PMID 17361109 DOI: 10.4161/hv.3.3.3925 |
0.343 |
|
| 2007 |
Lawrence G, Boyd I, McIntyre P, Isaacs D. Annual report: Surveillance of adverse events following immunisation in Australia, 2005. Communicable Diseases Intelligence Quarterly Report. 30: 319-33. PMID 17120485 |
0.324 |
|
| 2007 |
Wood N, McIntyre P, Wong M. Vaccination for the paediatrician. Journal of Paediatrics and Child Health. 42: 665-73. PMID 17044892 DOI: 10.1111/j.1440-1754.2006.00927.x |
0.35 |
|
| 2006 |
Menzies R, McIntyre P. Vaccine preventable diseases and vaccination policy for indigenous populations Epidemiologic Reviews. 28: 71-80. PMID 16763071 DOI: 10.1093/epirev/mxj005 |
0.323 |
|
| 2006 |
Hull BP, McIntyre PB. Timeliness of childhood immunisation in Australia. Vaccine. 24: 4403-8. PMID 16569467 DOI: 10.1016/J.VACCINE.2006.02.049 |
0.333 |
|
| 2006 |
Clements CJ, McIntyre PB. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines. Expert Opinion On Drug Safety. 5: 17-29. PMID 16370953 DOI: 10.1517/14740338.5.1.17 |
0.337 |
|
| 2005 |
Macartney KK, Beutels P, McIntyre P, Burgess MA. Varicella vaccination in Australia Journal of Paediatrics and Child Health. 41: 544-552. PMID 16398834 DOI: 10.1111/j.1440-1754.2005.00717.x |
0.359 |
|
| 2005 |
Macartney K, Mcintyre P. Universal varicella vaccination. Comment The Medical Journal of Australia.. 183: 278-279. PMID 16252446 |
0.327 |
|
| 2005 |
Andrews RM, Skull SA, Byrnes GB, Campbell DA, Turner JL, McIntyre PB, Kelly HA. Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria. Communicable Diseases Intelligence Quarterly Report. 29: 283-8. PMID 16220865 |
0.345 |
|
| 2005 |
Lawrence GL, Boyd I, McIntyre PB, Isaacs D. Annual report: surveillance of adverse events following immunisation in Australia, 2004. Communicable Diseases Intelligence Quarterly Report. 29: 248-62. PMID 16220860 |
0.341 |
|
| 2005 |
Menzies R, McIntyre P, Beard F. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002. Communicable Diseases Intelligence Quarterly Report. S1-45. PMID 16134530 |
0.335 |
|
| 2005 |
Wood N, Menzies R, McIntyre P. Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease. Internal Medicine Journal. 35: 530-5. PMID 16105154 DOI: 10.1111/j.1445-5994.2005.00909.x |
0.304 |
|
| 2005 |
Lawrence G, Boyd I, McIntyre P, Isaacs D. Surveillance of adverse events following immunisation: Australia 2002 to 2003. Communicable Diseases Intelligence Quarterly Report. 28: 324-38. PMID 15574056 |
0.338 |
|
| 2004 |
Brotherton J, McIntyre P, Puech M, Wang H, Gidding H, Hull B, Lawrence G, MacIntyre R, Wood N, Armstrong D. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. Communicable Diseases Intelligence Quarterly Report. 28: vii-S116. PMID 15732752 |
0.334 |
|
| 2004 |
McIntyre PB, Turnbull FM, Egan AM, Burgess MA, Wolter JM, Schuerman LM. High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine Vaccine. 23: 380-385. PMID 15530684 DOI: 10.1016/j.vaccine.2004.05.030 |
0.331 |
|
| 2004 |
Hull BP, McIntyre PB. What do we know about 7vPCV coverage in Aboriginal and Torres Strait Islander children? Communicable Diseases Intelligence Quarterly Report. 28: 238-43. PMID 15460962 |
0.323 |
|
| 2004 |
Menzies R, McIntyre P, Beard F. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002. Communicable Diseases Intelligence Quarterly Report. 28: 127-59. PMID 15460950 |
0.347 |
|
| 2004 |
McIntyre P. Vaccines for other neonatal infections: Vaccine strategies for prevention of neonatal pertussis Expert Review of Vaccines. 3: 375-378. PMID 15270638 DOI: 10.1586/14760584.3.4.375 |
0.307 |
|
| 2004 |
Scuffham PA, McIntyre PB. Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis. Vaccine. 22: 2953-64. PMID 15246632 DOI: 10.1016/J.VACCINE.2003.11.057 |
0.303 |
|
| 2004 |
Hethcote HW, Horby P, McIntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine. 22: 2181-91. PMID 15149775 DOI: 10.1016/J.Vaccine.2003.11.053 |
0.327 |
|
| 2004 |
Hull BP, McIntyre PB, Couzos S. Evaluation of immunisation coverage for aboriginal and Torres Strait Islander children using the Australian Childhood Immunisation Register. Australian and New Zealand Journal of Public Health. 28: 47-52. PMID 15108747 DOI: 10.1111/j.1467-842X.2004.tb00632.x |
0.316 |
|
| 2004 |
Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, Gilbert GL. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiology and Infection. 132: 185-93. PMID 15061492 DOI: 10.1017/S095026880300164X |
0.308 |
|
| 2004 |
Butler JRG, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B. The cost-effectiveness of pneumococcal conjugate vaccination in Australia Vaccine. 22: 1138-1149. PMID 15003641 DOI: 10.1016/J.Vaccine.2003.09.036 |
0.313 |
|
| 2004 |
Belshe RB, Newman FK, Tsai TF, Karron RA, Reisinger K, Roberton D, Marshall H, Schwartz R, King J, Henderson FW, Rodriguez W, Severs JM, Wright PF, Keyserling H, Weinberg GA, ... ... McIntyre P, et al. Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. The Journal of Infectious Diseases. 189: 462-70. PMID 14745704 DOI: 10.1086/381184 |
0.324 |
|
| 2003 |
Lawrence GL, MacIntyre CR, Hull BP, McIntyre PB. Measles vaccination coverage among five-year-old children: implications for disease elimination in Australia. Australian and New Zealand Journal of Public Health. 27: 413-8. PMID 14705304 DOI: 10.1111/j.1467-842X.2003.tb00419.x |
0.332 |
|
| 2003 |
Horby P, Gilmour R, Wang H, McIntyre P. Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. Communicable Diseases Intelligence Quarterly Report. 27: 324-41. PMID 14510058 |
0.311 |
|
| 2003 |
Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, Purcell P, Isaacs D. Surveillance of adverse events following immunisation: Australia, 2000-2002. Communicable Diseases Intelligence Quarterly Report. 27: 307-23. PMID 14510057 |
0.332 |
|
| 2003 |
Torvaldsen S, Simpson JM, McIntyre PB. Effectiveness of pertussis vaccination in New South Wales, Australia, 1996-1998. European Journal of Epidemiology. 18: 63-9. PMID 12705625 DOI: 10.1023/A:1022588118030 |
0.356 |
|
| 2003 |
MacIntyre CR, Burgess MA, Hull B, McIntyre PB. Hepatitis A vaccination options for Australia Journal of Paediatrics and Child Health. 39: 83-87. PMID 12603793 DOI: 10.1046/j.1440-1754.2003.00098.x |
0.326 |
|
| 2003 |
Torvaldsen S, Hull BP, McIntyre PB. Using the Australian Childhood Immunisation Register to track the transition from whole-cell to acellular pertussis vaccines. Communicable Diseases Intelligence Quarterly Report. 26: 581-3. PMID 12549528 |
0.331 |
|
| 2002 |
Nolan T, McIntyre P, Roberton D, Descamps D. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine. Vaccine. 21: 281-9. PMID 12450703 DOI: 10.1016/S0264-410X(02)00459-0 |
0.338 |
|
| 2002 |
Torvaldsen S, McIntyre PB. Observational methods in epidemiologic assessment of vaccine effectiveness. Communicable Diseases Intelligence Quarterly Report. 26: 451-7. PMID 12416713 |
0.329 |
|
| 2002 |
McIntyre P, Gidding H, Gilmour R, Lawrence G, Hull B, Horby P, Wang H, Andrews R, Burgess M. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Communicable Diseases Intelligence Quarterly Report. i-xi, 1-111. PMID 12194422 |
0.334 |
|
| 2000 |
McIntyre PB, Nolan TM. Conjugate pneumococcal vaccines for non-indigenous children in Australia. The Medical Journal of Australia. 173: S54-7. PMID 11062810 DOI: 10.5694/j.1326-5377.2000.tb139417.x |
0.351 |
|
| 1998 |
Burgess MA, McINtyre PB, Heath TC. Rethinking contraindications to vaccination Medical Journal of Australia. 168: 476-477. PMID 9631667 DOI: 10.5694/J.1326-5377.1998.TB141404.X |
0.326 |
|
| Show low-probability matches. |